-44.8%
IONQ vs MRNA
+342.9%
-387.6%
-63.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -9.4% | -7.0% | -2.4% | -9.2% |
| 7D | +16.8% | -4.2% | +20.9% | +17.0% |
| 30D | -11.1% | +7.0% | -18.1% | -11.2% |
| 3M | -31.7% | +263.4% | -295.1% | -32.7% |
| 6M | -44.8% | +334.3% | -379.1% | -48.0% |
| All | -44.8% | +342.9% | -387.6% | -48.0% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling